Analysis of Romanian Bacteroides isolates for antibiotic resistance levels and the corresponding antibiotic resistance genes

Anaerobe

Volumn 31, Issue , 2015, Pages 11-14

  Székely, Edit ^a,b   Eitel, Zsuzsa ^c   Molnár, Szabolcs ^a   Szász, Izabella Éva ^a   Bilca, Doina ^a   Sóki, József ^c  

^a Emergency Clinical Hospital   (Romania)

^b UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

^c UNIVERSITY OF SZEGED   (Hungary)

Author keywords

Antibiotic resistance genes; Antibiotic susceptibility; Bacteroides

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; ANTIBIOTIC AGENT; CEFOXITIN; CLINDAMYCIN; IMIPENEM; METRONIDAZOLE; MOXIFLOXACIN; PIPERACILLIN PLUS TAZOBACTAM; TETRACYCLINE; TIGECYCLINE; ANTIINFECTIVE AGENT;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC RESISTANCE GENE; ARTICLE; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIUM ISOLATE; BACTEROIDES; BACTEROIDES FRAGILIS; BACTEROIDES OVATUS; BACTEROIDES THETAIOTAOMICRON; BACTEROIDES VULGATUS; BEXA GENE; CEPA GENE; CFIA GENE; CFXA GENE; ERMB GENE; ERMF GENE; GENE FUNCTION; GENE IDENTIFICATION; LINA GENE; MINIMUM INHIBITORY CONCENTRATION; MSRSA GENE; MULTIDRUG RESISTANCE; NIMB GENE; NONHUMAN; ROMANIA; SATG GENE; STRAIN DIFFERENCE; TETM GENE; TETX GENE; BACTEROIDES INFECTIONS; DRUG EFFECTS; GENETICS; HUMAN; ISOLATION AND PURIFICATION; MICROBIOLOGY; PREVALENCE;

BACTEROIDES; BACTEROIDES FRAGILIS;

ANTI-BACTERIAL AGENTS; BACTEROIDES FRAGILIS; BACTEROIDES INFECTIONS; DRUG RESISTANCE, BACTERIAL; GENES, BACTERIAL; HUMANS; PREVALENCE; ROMANIA;

EID: 84922707970     PISSN: 10759964     EISSN: 10958274     Source Type: Journal    
DOI: 10.1016/j.anaerobe.2014.09.001     Document Type: Article

References (15)

1. Snydman D.R., Jacobus N.V., McDermott L.A., Golan Y., Hecht D.W., Goldstein E.J.C., et al. Lessons learned from the anaerobe survey: historical perspective and review of most recent data (2005-2007). Clin Infect Dis 2010, 50:S26-S33.
2. Nagy E., Urbán E., Nord C.E. Bacteria obotESGoARiA. Antimicrobial susceptibility of Bacteroides fragilis group isolates in Europe 20 years of experience. Clin Microbiol Infect 2011, 17:371-379.
3. Wybo I., Van den Bossche D., Soetens O., Vekens E., Vandoorslaer K., Claeys G., et al. Fourth Belgian multicentre survey of antibiotic susceptibility of anaerobic bacteria. JAntimicrob Chemother 2014, 69:155-161.
4. Karlowsky J.A., Walkty A.J., Adam H.J., Baxter M.R., Hoban D.J., Zhanel G.G. Prevalence of antimicrobial resistance among clinical isolates of Bacteroides fragilis group in Canada in 2010-2011: CANWARD surveillance study. Antimicrobial Agents Chemother 2012, 56:1247-1252.
5. Eitel Z., Sóki J., Urbán E., Nagy E. The prevalence of antibiotic resistance genes in Bacteroides fragilis group strains isolated in different European countries. Anaerobe 2013, 21:43-49.
6. Sóki J., Eitel Z., Urbán E., Nagy E. Molecular analysis of the carbapenem and metronidazole resistance mechanisms of Bacteroides strains reported in a Europe-wide antibiotic resistance survey. Int J Antimicrob Agents 2013, 41:122-125.
7. Citron DMP I.R., Baron E.J. Bacteroides, Porphyromonas, Prevotella, Fusobacterium, and other gram-negative rods. Manual of clinical microbiology 2007, 911-932. American Society for Microbiology, Washington, DC. E.J. Murray PRB, J.H. Jorgensen, M.L. Landry, M.A. Pfaller (Eds.).
8. Hedberg M., Nord C.E. Antimicrobial susceptibility of Bacteroides fragilis group isolates in Europe. Clin Microbiol Infect 2003, 9:475-488. on behalf of the ESGoARiAB.
9. Marina M., Ivanova M., Kantardjiev T. Antimicrobial susceptibility of anaerobic bacteria in Bulgaria. Anaerobe 2009, 15:127-132.
10. Sóki J., Gonzalez S.M., Urbán E., Nagy E., Ayala J.A. Molecular analysis of the effector mechanisms of cefoxitin resistance among Bacteroides strains. JAntimicrob Chemother 2011, 66:2492-2500.
11. Molina J., Barrantes G., Quesada-Gomez C., Rodriguez-Cavallini E. Phenotypic and genotypic characterization of multidrug-resistant Bacteroides, Parabacteroides spp., and Pseudoflavonifractor from a Costa Rican Hospital. Mirob Drug Resist 2014 mar 7, [Epub ahead of print] http://dx.doi.org/10.1089/mdr.2013.0180.
12. Cordero-Laurent ER C., Rodriguez-Cavallini E., del Mar Gamboa-Coronado M., Quesada-Gómez C. Resistance of Bacteroides isolates recovered among clinical samples from a major Costa-Rican hospital between 2000 and 2008 to β-lactams, clindamycin, metronidazole, and chloramphenicol. Rev Esp Quimioter 2012, 25:261-265.
13. Wang Y., Wang G.-R., Shelby A., Shoemaker N.B., Salyers A.A. Anewly discovered Bacteroides conjugative transposon, CTnGERM1, containes genes also found in gram-positive bacteria. Appl Environ Microbiol 2003, 69. 4595-4546-4593.
14. Bachoual R., Dubreuil L., Soussy C.-J., Tankovic J. Roles of gyrA mutations in resistance of clinical isolates and invitro mutants of Bacteroides fragilis to the new Fluoroquinolone Trovafloxacin. Antimicrobial Agents Chemother 2000, 44:1842-1845.
15. Ricci V., Peterson M.L., Rotschafer J.C., Wexler H., Piddock L.J.V. Role of Topoisomerase mutations and efflux in Fluoroquinolone resistance of Bacteroides fragilis clinical isolates and laboratory mutants. Antimicrobial Agents Chemother 2004, 48:1344-1346.